Time To Second Progression (Pfs2) In Patients (Pts) From Titan With Metastatic Castration-Sensitive Prostate Cancer (Mcspc) By First Subsequent Therapy (Hormonal Vs. Taxane)

Neeraj Agarwal,Simon Chowdhury,Anders Bjartell,Byung Ha Chung,Andrea Juliana Pereira de Santana Gomes,Robert W. Given,Álvaro Juárez Soto,Axel Stuart Merseburger,Mustafa Ozguroglu,Hirotsugu Uemura,Dingwei Ye,Anil Londhe,Angela Lopez-Gitlitz,Sharon Anne McCarthy,Suneel Mundle,Kim N. Chi

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 15|浏览122

暂无评分

摘要

82Background: TITAN, a phase 3, randomized, double-blind study of apalutamide (APA) vs placebo (PBO) added to androgen deprivation therapy (ADT), demonstrated significant improvement in radiographi...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要